The supplement industry is large, fast-growing, and—compared to prescription drugs—lightly regulated before products hit the market. The FDA does not require dietary supplements to go through pre-market approval for safety or effectiveness before they are sold. Under current law, the responsibility to ensure a product is safe and accurately labeled starts with the brand and the manufacturer. FDA oversight often comes after a product is already on shelves.
That regulatory reality matters for consumers—because it means the phrase "lab tested" can mean almost anything.
A brand might conduct internal quality checks. It might rely on a Certificate of Analysis provided by its manufacturer. It might send a single batch to a lab once and never test again. None of those approaches are the same as systematic, independent, lot-by-lot verification—and none of them give the customer the same level of assurance.
Independent testing has shown that the risks are real, not hypothetical. A 2023 GAO report found that 11 of 12 best-selling prenatal supplements had at least one nutrient tested outside acceptable label deviation ranges (1). That kind of inaccuracy isn't a manufacturing outlier—it's a systemic quality gap, and exactly the problem that lot-by-lot, independent verification is designed to catch.
A 2025 investigation from Consumer Reports tested 23 protein powders and ready-to-drink shakes and found that more than two-thirds of tested products contained lead above Consumer Reports' daily level of concern (2).
These findings are not an indictment of the entire category. But they are a clear argument for why customer trust has to be earned with evidence—not assumed based on a label.